May the Nitrosative and Carbonyl Stress Promote Inflammation in Patients with Colorectal Cancer?
colorectal cancer
cytokines
inflammation
nitrosative stress
Journal
Journal of inflammation research
ISSN: 1178-7031
Titre abrégé: J Inflamm Res
Pays: New Zealand
ID NLM: 101512684
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
06
2022
accepted:
22
07
2022
entrez:
18
8
2022
pubmed:
19
8
2022
medline:
19
8
2022
Statut:
epublish
Résumé
Overproduction of reactive nitrogen species (RNS) causes the nitrosative stress, which plays a vital role in the development of metabolic, inflammatory, and cancerous diseases. However, the role of nitrosative and carbonyl stress in the biology of colorectal cancer (CRC) is still not well understood. Therefore, this study evaluated nitrosative stress, protein and DNA oxidation/glycoxidation, and pro- and anti-inflammatory cytokines in CRC patients compared with healthy controls. Fifty-five CRC patients (21 women, 34 men) and 55 healthy controls matched for sex and age were included in the experiment. Nitrosative stress parameters (nitric oxide (NO), peroxynitrite, S-nitrosothiols, and nitrotyrosine), protein oxidation (total thiols) and glycoxidation products (kynurenine N-formylkynurenine, dityrosine, Amadori products, and amyloid), and DNA damage markers (8-hydroxydeoxyguanosine (8-OHdG)), as well as levels of pro- and anti-inflammatory cytokines, were measured in serum or plasma samples. The levels of NO, peroxynitrite, S-nitrosothiols, nitrotyrosine, total thiols, kynurenine, N-formylkynurenine, dityrosine, Amadori product, amyloid, and 8-OHdG, as well as IL1α, IL1β, IL6, IL10, and TNF-α, were significantly higher in CRC patients than in controls. Oxidation and glycoxidation products were positively correlated with pro-inflammatory (IL1α, IL1β, IL6, TNFα) and anti-inflammatory cytokines (IL10), indicating that redox damages may promote inflammation in CRC patients. Many redox biomarkers differentiate patients with CRC from healthy individuals with high sensitivity and specificity. Correlations of chosen oxidative products with pro-inflammatory (IL1α, IL1β, IL6, TNFα) and anti-inflammatory cytokines (IL10) suggest that redox damages may promote inflammation in CRC patients. Thus, our research is the first point for further clinical trials focusing on the evaluation of the diagnostic utility of nitrosative stress biomarkers in a larger group of CRC patients.
Identifiants
pubmed: 35979507
doi: 10.2147/JIR.S374387
pii: 374387
pmc: PMC9377401
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4585-4600Informations de copyright
© 2022 Dorf et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Cent Eur J Immunol. 2018;43(2):174-179
pubmed: 30135630
Cell Stress. 2020 Jan 03;4(1):24-26
pubmed: 31922097
Free Radic Biol Med. 2021 Nov 1;175:108-120
pubmed: 34390781
Cancers (Basel). 2019 Oct 08;11(10):
pubmed: 31597313
Ann Intern Med. 1990 Nov 15;113(10):779-88
pubmed: 2240880
Cancers (Basel). 2010 Mar 26;2(2):274-304
pubmed: 24281071
Methods Enzymol. 1999;309:274-84
pubmed: 10507030
Cancers (Basel). 2020 Nov 11;12(11):
pubmed: 33187272
Oxid Med Cell Longev. 2017;2017:8416763
pubmed: 28819546
J Biochem Pharmacol Res. 2013 Mar;1(1):15-26
pubmed: 23662248
Carcinogenesis. 2021 Dec 31;42(12):1411-1419
pubmed: 34415330
J Clin Med. 2019 Jun 12;8(6):
pubmed: 31212834
Cancer Lett. 2008 Jul 18;266(1):73-83
pubmed: 18367325
Antioxidants (Basel). 2021 Apr 22;10(5):
pubmed: 33922139
Oxid Med Cell Longev. 2016;2016:7432797
pubmed: 27738491
World J Surg Oncol. 2013 May 30;11:118
pubmed: 23718886
JAMA. 2021 Feb 16;325(7):669-685
pubmed: 33591350
Oxid Med Cell Longev. 2022 Feb 25;2022:4048543
pubmed: 35251471
Arch Biochem Biophys. 1959 May;82(1):70-7
pubmed: 13650640
Methods Enzymol. 1996;268:237-46
pubmed: 8782590
Antioxidants (Basel). 2020 Nov 04;9(11):
pubmed: 33158288
Oxid Med Cell Longev. 2016;2016:1245049
pubmed: 27478531
Arch Biochem Biophys. 1992 Nov 1;298(2):438-45
pubmed: 1416975
Nature. 2008 Apr 3;452(7187):646-9
pubmed: 18344980
Front Physiol. 2017 Jun 07;8:386
pubmed: 28638348
Ir J Med Sci. 2017 Feb;186(1):57-62
pubmed: 27156054
Cancer Manag Res. 2021 Aug 12;13:6329-6348
pubmed: 34408493
Nutr J. 2016 Jul 25;15(1):71
pubmed: 27456681
Clin Chem. 1987 Oct;33(10):1955-6
pubmed: 3665082
Cell Res. 2002 Dec;12(5-6):311-20
pubmed: 12528889
Methods Enzymol. 1999;301:201-11
pubmed: 9919568
Anticancer Res. 2006 Nov-Dec;26(6B):4235-43
pubmed: 17201139
Gastroenterology. 2011 May;140(6):1807-16
pubmed: 21530747
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009 Apr;27(2):120-39
pubmed: 19412858
Clin Diagn Lab Immunol. 1998 Jul;5(4):438-45
pubmed: 9665945
Hum Immunol. 2013 Oct;74(10):1392-9
pubmed: 23777924
J Clin Med. 2019 Jan 21;8(1):
pubmed: 30669680
Signal Transduct Target Ther. 2021 Jul 12;6(1):263
pubmed: 34248142
PLoS One. 2015 Mar 03;10(3):e0118612
pubmed: 25734426